Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · IEX Real-Time Price · USD

0.721

-0.049 (-6.36%)

At close: Apr 19, 2024, 3:59 PM

0.711

-0.010 (-1.46%)

After-hours: Apr 19, 2024, 5:44 PM EDT

Aptevo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	0	3.11	12.29	4.31	0	23.07	14.66	9.99	33.6	45.63	Upgrade
Revenue Growth (YoY)	-	-74.67%	185.26%	-	-	57.37%	46.80%	-70.28%	-26.36%	26741.76%	Upgrade
Cost of Revenue	0	0	0	0	0	11.21	5.01	12.47	16.93	16.25	Upgrade
Gross Profit	0	3.11	12.29	4.31	0	11.85	9.65	-2.48	16.67	29.38	Upgrade
Selling, General & Admin	11.77	13.87	14.7	13.95	16.2	28.13	34.58	36.16	43.04	34.28	Upgrade
Research & Development	17.11	17.88	18.99	17.85	24.76	35.39	29.02	29.12	34.73	46.59	Upgrade
Other Operating Expenses	0	0	0	1.33	0	0	0	71.01	0	0.22	Upgrade
Operating Expenses	28.88	31.76	33.69	33.13	40.96	63.52	63.6	136.29	77.77	81.09	Upgrade
Operating Income	-28.88	-28.64	-21.4	-28.82	-40.96	-51.67	-53.95	-138.77	-61.1	-51.71	Upgrade
Other Expense / Income	-11.47	-36.67	7.06	-11.07	-0.51	2.02	-37.62	-6.67	0.24	-	Upgrade
Pretax Income	-17.41	8.03	-28.46	-17.75	-40.45	-53.69	-16.33	-132.11	-61.34	-51.71	Upgrade
Income Tax	0	0	0	0	0	0	-23.3	-19.69	-2.02	-0.6	Upgrade
Net Income	-17.41	8.03	-28.46	-17.75	-40.45	-53.69	6.97	-112.42	-59.32	-51.12	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	0	0	0	0	-	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	0	0	0	0	-	Upgrade
Shares Change	139.76%	8.85%	38.25%	16.25%	81.50%	5.46%	5.41%	0.05%	-	-	Upgrade
EPS (Basic)	-62.48	69.08	-267.08	-230.12	-609.84	-1472.24	203.28	-3418.80	-1804.88	-	Upgrade
EPS (Diluted)	-62.48	69.08	-267.08	-230.12	-609.84	-1472.24	203.28	-3418.80	-1804.88	-	Upgrade
Free Cash Flow	-11.73	-21.05	-22.39	-29.41	-42.54	-52.4	-42.98	-39.37	-50.29	-48	Upgrade
Free Cash Flow Per Share	-42.19	-181.60	-210.17	-381.57	-641.61	-1434.54	-1240.80	-1198.39	-1531.24	-	Upgrade
Gross Margin	-	100.00%	100.00%	100.00%	-	51.39%	65.82%	-24.86%	49.61%	64.38%	Upgrade
Operating Margin	-	-919.75%	-174.10%	-668.81%	-	-223.98%	-368.05%	-1389.81%	-181.84%	-113.33%	Upgrade
Profit Margin	-	257.77%	-231.51%	-411.93%	-	-232.75%	47.57%	-1125.84%	-176.53%	-112.02%	Upgrade
Free Cash Flow Margin	-	-676.01%	-182.17%	-682.43%	-	-227.16%	-293.18%	-394.33%	-149.66%	-105.18%	Upgrade
EBITDA	-16.84	8.93	-27.31	-16.34	-38.21	-51.3	-13.2	-128.75	-58.43	-49.69	Upgrade
EBITDA Margin	-	286.71%	-222.20%	-379.30%	-	-222.39%	-90.06%	-1289.38%	-173.89%	-108.90%	Upgrade
Depreciation & Amortization	0.57	0.9	1.14	1.41	2.24	2.39	3.13	3.36	2.91	2.02	Upgrade
EBIT	-17.41	8.03	-28.46	-17.75	-40.45	-53.69	-16.33	-132.11	-61.34	-51.71	Upgrade
EBIT Margin	-	257.77%	-231.51%	-411.93%	-	-232.75%	-111.39%	-1323.05%	-182.55%	-113.33%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).